← Back to all signals
RESEARCH PAPER ANALYSIS

Fusion-specific co-mutational architecture and treatment-response associations in pediatric core-binding factor acute myeloid leukemia: a multicenter exome-profiled cohort.

AI interpretation is pending for this paper.

Open original publication →
PMID42876759
JournalFrontiers in oncology
Publication Date2026-09-30
Ingested2026-10-17 09:15 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

INTRODUCTION: Core-binding factor acute myeloid leukemia (CBF-AML) is defined by one of two founding fusions, but cooperating lesions may differ between fusion subtypes. We characterized the broader diagnostic co-mutational architecture of pediatric CBF-AML and examined its relationship with post-induction measurable residual disease (MRD) and outcome. METHODS: This retrospective analysis included 170 children with diagnostic whole-exome sequencing (WES) data (2019-2023), a subset of a reported 289-patient cohort. Candidate leukemia-associated variants were curated conservatively because matched normal samples were unavailable. Variant frequencies were compared between RUNX1::RUNX1T1 and CBFB::MYH11 AML with false-discovery-rate control. Associations with MRD were tested using Fisher's exact test. Primary feature-specific Cox models for event-free survival (EFS) were adjusted only for fusion subtype and induction regimen; sensitivity analyses additionally addressed age and presenting WBC count, MRD, and transplantation. RESULTS: In a limited selection audit, fusion-subtype and FLT3-ITD distributions were similar between WES-included and non-included patients, whereas clinical-source KIT positivity was more frequent in the WES subset. The analytic cohort included 138 RUNX1::RUNX1T1 and 32 CBFB::MYH11 cases; 137 received FLAG-IDA, and 33 received DAE induction. At least one curated candidate variant was present in 135 patients (79.4%), and 69 (40.6%) had alterations in two or more genes. Tyrosine-kinase signaling alterations occurred in 115 patients (67.6%). RAS-pathway alterations were enriched in CBFB::MYH11 AML (53.1% vs. 19.6%; P < 0.001, q=0.002), driven principally by NRAS (50.0% vs. 15.2%; P < 0.001, q < 0.001). Chromatin-modifier alterations were numerically enriched in RUNX1::RUNX1T1 AML (24.6% vs. 6.2%; P = 0.028) but did not remain significant after multiplicity correction (q=0.114). After false-discovery-rate correction, no tested genomic feature was associated with MFC-MRD or molecular MRD positivity after the second induction. With a median follow-up of 33.2 months, 3-year EFS and overall survival were 84.2% and 89.8%, respectively. No baseline genomic feature showed a significant association with EFS in either the primary or expanded baseline-covariate models. CONCLUSIONS: Among WES-profiled patients, pediatric CBF-AML showed fusion-specific co-mutational architecture, especially RAS-pathway enrichment in CBFB::MYH11 AML. In this WES-defined cohort, baseline genomic features were not established as response or outcome predictors. These findings are descriptive and hypothesis-generating; they do not support treatment-specific causal inference.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Polyorchidism in Children: Preserve, Fix, or Remove the Supernumerary Testis? Cureus 58.4 2 Processed Electroencephalography-Guided Total Intravenous Anesthesia in a Malignant Hyperthermia-Susceptible Child Undergoing Ventricular Septal Defect Repair: A Case Report. Cureus 47.5 3 Anatomical Structures as Graph Nodes: Representation Before Architecture in Paediatric Brain Tumour Localisation. Diagnostics (Basel, Switzerland) 58.7 4 Pilomatricoma in Turner Syndrome: Association with Renal Malformations and Analysis of the Vitamin D Pathway. International journal of molecular sciences 59.0 5 Germline AIP Testing in Pituitary Neuroendocrine Tumors: Diagnostic Yield, Variant Interpretation, and a Phenotype-Driven Clinical Approach-A Narrative Review. Diagnostics (Basel, Switzerland) 70.0 6 Recent Therapeutic Improvements in Pediatric Oncology: One Fellow Generation (2020-2025). Cancers 83.94 7 Exercise Interventions Incorporating Aerobic Components in Children and Adolescents with Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis. Cancers 81.5 8 Pediatric Extraspinal Sacrococcygeal Ependymoma: A Structured Narrative Review of Published Cases and Diagnostic Challenges. Cancers 60.9 9 From Pan-T-Cell Depletion to Selective Graft Engineering: Progress, Limitations, and Open Questions. Journal of clinical medicine 73.5 10 Beyond BMI: Roles of SPISE, Central Adiposity and Body Composition in Pediatric Brain Tumor Survivors. Cancers 66.3 11 Correction: Zamora-Herrera et al. Low-Intensity CD66c Expression Orchestrates an Immunosuppressive Niche Promoting Residual Disease in Pediatric ProB Acute Lymphoblastic Leukemia. Cells 2026, 15, 437. Cells 49.5 12 Frequent PRAME Expression in Ameloblastoma: Immunohistochemical Profiling, Clinicopathologic Correlations, and Interobserver Reproducibility in a 37-Case Cohort. International journal of molecular sciences 67.4 13 Moving beyond the tracer conditions: positioning childhood cancer within the scale-up of PEN-Plus in Africa. Frontiers in oncology 58.4 14 Age-specific HPV genotype distribution and associations with cervical lesions and vaginal microecological status in Northeast China: a retrospective study of 73,828 individuals. Frontiers in cellular and infection microbiology 63.0 15 Case Report: Sodium glucose cotransporter 2 inhibitor use in a pediatric patient with cancer receiving cisplatin. Frontiers in pediatrics 54.86 16 Correction: A case report: axillary ALK-positive anaplastic large-cell lymphoma mimicking an infectious abscess in an adolescent. Frontiers in oncology 41.0 17 Editorial Comment on Prevalence and Associated Factors of Erectile Dysfunction in Japanese Adolescent and Young Adult (AYA) Male Cancer Survivors. International journal of urology : official journal of the Japanese Urological Association 47.5 18 Non-carcinogenic and carcinogenic health risk assessment of heavy metals in groundwater near the Erbil Oil Refinery, Kurdistan Region, Iraq. Journal of environmental quality 57.5 19 Fertility-Related Distress in Young Adult Survivors of Childhood Cancer: Prevalence and Key Predictors. Cancer medicine 72.0 20 Neurofibromatosis Type 1: Clinical and Molecular Characterization in a Romanian Cohort of 80 Patients. Diagnostics (Basel, Switzerland) 59.0 21 FOXM1 Targets TRIM59 to Activate Wnt/β-Catenin in Tumor Stemness and Hepatoblastoma Metastasis. International journal of molecular sciences 51.9 22 Clinical Features, Genetics and Treatment in a Russian Cohort of Young Patients with Xeroderma Pigmentosum: A Single Center Experience. International journal of molecular sciences 68.24 23 Ovarian Preservation Before Puberty: Surgical Management of Adnexal Torsion in Prepubertal and Prepubertal-Predominant Paediatric Cohorts-A Systematic Review and Meta-Analysis. Journal of clinical medicine 73.0 24 Excess Cardiovascular Burden Among Young Patients with Cancer: A Systematic Review and Meta-Analysis. Cancers 75.4 25 ABCC2 Genetic Variation and Vincristine-Induced Peripheral Neuropathy Risk in Mexican Pediatric Patients with Acute Lymphoblastic Leukemia. International journal of molecular sciences 73.9 26 The Swedish childhood cancer quality registry for risk-based long-term follow-up after childhood cancer: structure, content, and development over time. Archives of public health = Archives belges de sante publique 73.7 27 Compromised Endothelial Regeneration as a Potential Contributor to Long-Term Cardiovascular Complications in Childhood Cancer Survivors. Cells 77.6 28 Clinical Presentations of Pseudomonas aeruginosa Infection in Children with Leukaemia Treated with Chemotherapy-A Series of 5 Cases with Discussion. Journal of clinical medicine 73.04 29 Clinical, virological and immunological characteristics of people living with HTLV at a Swedish tertiary referral center. BMC infectious diseases 61.5 30 Mind the uncertainties - a cross-sectional study on perceptions of cancer risks for factors with inconclusive or limited evidence among the Swedish general public. BMC public health 66.0 31 Interpretation of NMD-Escaping Variants with Activating Mechanisms in Cancer Genes. Genetics in medicine : official journal of the American College of Medical Genetics 58.95 32 Intraoperative technology in skull base and vascular neurosurgery: a two-stage cross-sectional national survey. Neurosurgical review 60.2
PATIENT-FRIENDLY SUMMARY

Fusion-specific co-mutational architecture and treatment-response associations in pediatric core-binding factor acute myeloid leukemia: a multicenter exome-profiled cohort.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic